Simultaneously, the downregulation of WNT16, cell cycle regulators such as SLC7A5, and histone genes, like HIST2H3A and HIST1H2BJ, points to disruptions in the Wnt signaling and chromatin remodeling, processes central to cancer cell proliferation and epigenetic regulation (5, 38–41). This evidence concerns the gene H2BC11 and cancer.